Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  HIV Infection

  Free Subscription

Articles published in Virology

Retrieve available abstracts of 15 articles:
HTML format

Single Articles

    September 2021
  1. MACDONALD-OTTEVANGER MS, Boyd A, Prins M, van der Helm JJ, et al
    Differences in prevalence of hepatitis B virus infection and genotypes between ethnic populations in Suriname, South America.
    Virology. 2021;564:53-61.
    PubMed     Abstract available

    July 2021
  2. OEYEN M, Meyen E, Noppen S, Claes S, et al
    Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
    Virology. 2021;562:74-86.
    PubMed     Abstract available

  3. KRUIZE Z, Cobos Jimenez V, Martinez FO, Di Vincenzo R, et al
    CD9 and ITGA3 are regulated during HIV-1 infection in macrophages to support viral replication.
    Virology. 2021;562:9-18.
    PubMed     Abstract available

  4. ALFADHLI A, Romanaggi C, Barklis RL, Merutka I, et al
    Capsid-specific nanobody effects on HIV-1 assembly and infectivity.
    Virology. 2021;562:19-28.
    PubMed     Abstract available

    June 2021
  5. DESROSIERS V, Barat C, Breton Y, Ouellet M, et al
    Thymidylate synthase is essential for efficient HIV-1 replication in macrophages.
    Virology. 2021;561:47-57.
    PubMed     Abstract available

    March 2021
  6. BELSHAN M, Holbrook A, George JW, Durant HE, et al
    Discovery of candidate HIV-1 latency biomarkers using an OMICs approach.
    Virology. 2021;558:86-95.
    PubMed     Abstract available

    February 2021
  7. ANGERSTEIN AO, Stoneham CA, Ramirez PW, Guatelli JC, et al
    Corrigendum to "Sensitivity to monoclonal antibody 447-52D and an open env trimer conformation correlate poorly with inhibition of HIV-1 infectivity by SERINC5" [Virology 2020 548, 73-81].
    Virology. 2021 Feb 10. pii: S0042-6822(21)00035.

  8. MONDAL S, Karmakar A, Mallick T, Begum NA, et al
    Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Virology. 2021;556:133-139.
    PubMed     Abstract available

  9. JAGUVA VASUDEVAN AA, Balakrishnan K, Franken A, Krikoni A, et al
    Murine leukemia virus resists producer cell APOBEC3A by its Glycosylated Gag but not target cell APOBEC3A.
    Virology. 2021;557:1-14.
    PubMed     Abstract available

    January 2021
  10. RABINOWITZ J, Sharifi HJ, Martin H, Marchese A, et al
    xCT/SLC7A11 antiporter function inhibits HIV-1 infection.
    Virology. 2021;556:149-160.
    PubMed     Abstract available

    December 2020
  11. OJWACH DBA, Madlala P, Gordon M, Ndung'u T, et al
    Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Virology. 2020;554:1-8.
    PubMed     Abstract available

  12. ZHANG Z, Perkovic M, Gu Q, Balakrishnan K, et al
    HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms.
    Virology. 2020;554:17-27.
    PubMed     Abstract available

    October 2020
  13. MCQUAID IK, Dorfman JR, Mall AS
    The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
    Virology. 2020;553:1-8.
    PubMed     Abstract available

    September 2020
  14. SHA SS, Dai Z, Wei QZ, Tao HX, et al
    Characteristics of HIV-1 env genes from Chinese chronically infected donors with highly broad cross-neutralizing activity.
    Virology. 2020;551:16-25.
    PubMed     Abstract available

  15. WIECZOREK L, Peachman K, Steers N, Schoen J, et al
    Selection and immune recognition of HIV-1 MPER mimotopes.
    Virology. 2020;550:99-108.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.